Skip to main content
. 2019 Aug 5;25:5813–5822. doi: 10.12659/MSM.915472

Figure 5.

Figure 5

(A) Meta-analysis of plasma mSEPT9-positive rate in CRC and adenoma cases. (B) Funnel plots of plasma mSEPT9-positive rate in CRC and adenoma cases.